Drugs / PYM50028
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT01060878 | Nov 2010 → Dec 2012 | Parkinson disease | Phytopharm | Completed | No outcome recorded |
| Phase 2 | NCT00130429 | Jan 2004 → Sep 2005 | Alzheimer disease | Phytopharm | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | PYM50028 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00130429 ↗ |
| Known as | Cogane | “Investigation of Cogane (PYM50028) in Early-stage Parkinson's Disease (CONFIDENT-PD)” NCT01060878 ↗ |